DOCSLIB.ORG

Drug Discovery and Development with Plant-Derived Compounds

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Drug Discovery and Development with Plant-Derived Compounds Progress in Drug Research Founded by Ernst Jucker Series Editors Prof. Dr. Paul L. Herrling Alex Matter, M.D., Director Novartis International AG Novartis Institute for Tropical Diseases CH-4002 Basel 10 Biopolis Road, #05-01 Chromos Switzerland Singapore 138670 Singapore Progress in Drug Research Natural Compounds as Drugs Volume I Vol. 65 Edited by Frank Petersen and René Amstutz Birkhäuser Basel • Boston • Berlin Editors Frank Petersen René Amstutz Novartis Pharma AG Lichtstrasse 35 4056 Basel Switzerland Library of Congress Control Number: 2007934728 Bibliographic information published by Die Deutsche Bibliothek Die Deutsche Bibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data is available in the internet at http://dnb.ddb.de ISBN 978-3-7643-8098-4 Birkhäuser Verlag AG, Basel – Boston – Berlin The publisher and editor can give no guarantee for the information on drug dosage and administration contained in this publication. The respective user must check its accuracy by consulting other sources of reference in each individual case. The use of registered names, trademarks etc. in this publication, even if not identified as such, does not imply that they are exempt from the relevant protective laws and regulations or free for general use. This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, re-use of illustrations, recitation, broad- casting, reproduction on microfilms or in other ways, and storage in data banks. For any kind of use, permission of the copyright owner must be obtained. © 2008 Birkhäuser Verlag AG Basel · Boston · Berlin P.O. Box 133, CH-4010 Basel, Switzerland Part of Springer Science+Business Media Printed on acid-free paper produced from chlorine-free pulp. TCF ∞ Cover design and layout: Micha Lotrovsky, CH-4106 Therwil, Switzerland Printed in Germany ISBN 978-3-7643-8098-4 e-ISBN 978-3-7643-8117-2 9 8 7 6 5 4 3 2 1 www.birkhauser.ch Contents Foreword. vii Glossar. ix Mother nature’s gifts to diseases of man: The impact of natural products on anti-infective, anticholestemics and anticancer drug discovery . 1 Mark S. Butler and David J. Newman Drug discovery and development with plant-derived compounds . 45 Olivier Potterat and Matthias Hamburger Evolutionary mechanisms underlying secondary metabolite diversity . 119 Holger Jenke-Kodama, Rolf Müller and Elke Dittmann Biodiversity, chemical diversity and drug discovery . 141 Sheo B. Singh and Fernando Pelaez High impact technologies for natural products screening. 175 Frank E. Koehn Virtual screening for the discovery of bioactive natural products . 211 Judith M. Rollinger, Hermann Stuppner and Thierry Langer Strain improvement for production of pharmaceuticals and other microbial metabolites by fermentation . 251 Arnold L. Demain and Jose L. Adrio v Table of contents Nutritional and engineering aspects of microbial process development . 291 Prakash S. Masurekar Natural products from plant cell cultures. 329 Elizabeth McCoy and Sarah E. O’Connor Index . 371 vi Foreword The use of herbal medicines, their preparation and application in human therapy, was described for the first time in history by the Sumerians approximately 5000 years ago. Even earlier in India and China, a highly sophisticated medical system with plant-based therapies had been devel- oped. Along with the rise of the later empires, this knowledge was further expanded and institutionalized, while moving westwards to Egypt, Greece, and to the Arabic world, having a considerable influence on human ther- apy – until today. Not all of these traditional medicines, although partially in medical practice still today, can be considered as efficacious or useful according to Western therapeutic standards, often due to the fact that the tradi- tional disease categories cannot be easily translated into the “language” of Western medicine. The identification of active principles from plant preparations often failed, as the biological activity could not be enriched. However, there are numerous examples like morphine, quinine, salicylic acid, rivastigmine, digitalis glycosides, reserpine, or artemisinine, where the correlation between plant extract and the modern medicine, based on a single entity drug, was successfully established. All of these natural prod- ucts originated from traditional medical practice and opened the door to today’s medical indication areas, fundamentally enriching our knowledge of the pathophysiology and underlying biochemistry of diseases. The successful market introduction of a drug requires a continuous financial engagement over approx. 12 years and finally an investment of US $ 1 to 1.5 billion, including capital costs. Although these figures steeply increased during the last decade and continue to follow this trend, the success of the pharmaceutical industry as mirrored in the numbers of filed new molecular entities (NMEs) and the development of new therapies for unmet medical needs can be considered at best modest. The investments during the last 15 years in innovative technologies like the “omics” world for target finding, target validation and the strongly improved capabilities to populate the chemical space by combinatorial concepts, still need to deliver on the financial figures. During the same time period, research in natural products has largely been abandoned in drug discovery and development, mainly by the US vii Foreword American and British pharmaceutical industry, and has been reduced in almost all other companies – at a first glance for some good reasons. The molecules from nature are a weak starting point in today’s high throughput screening and lead development processes. The extremely time- sensitive process from uHTS, the capability to validate millions of com- pounds on a given target and the identification of suitable starting points for medicinal chemists was squeezed together to a few weeks. Natural prod- ucts were hardly adjustable to these new principles of lead identification. They are tested either as enriched mixtures, whereby the identification of the biologically active compound is achieved in intolerably repetitive and cumbersome process steps, or as pure compounds, often limited with respect to numbers and amounts. The vast majority of the natural products in the screening libraries are mainly singletons, unsuited for any hit explo- sion efforts. The chemical complexity of a natural product hampers also the engagement of medicinal chemists in industry. Synthetic molecules are often understood as a more auspicious alternative to reach the number of derivatives, as defined and accordingly rewarded in a project-driven indus- trial environment. A HTS campaign yields a variety of synthetic compound families interacting with the target of interest. Therefore a structure-activity relationship is immediately available with the submission of a hit list. There are, however, solid arguments to leverage the molecules from nature in drug discovery. Besides the impressive success story in the phar- maceutical industry, natural products cover a unique breadth of biologi- cally functionalized, complementary chemical diversity in comparison to other library types, are still sources for new pharmacophore classes, or represent a promising starting point to intervene with protein-protein interactions, to mention only a few opportunities to address current areas of pressing need in drug discovery. With the books Natural Products as Drugs Vol I and II we aim to show not only the complex technology catalogue applicable to natural products in drug development-related science. Important additional motivations for the current edition have been to demonstrate how natural products can successfully be integrated in most technologies and concepts of modern drug discovery and to illustrate their potential for innovative treatments of human diseases. The chapters cover topics from applied biodiversity considerations in natural products discovery, screening concepts, dereplication technologies viii Foreword to the fermentation aspects of microbially and plant-derived secondary metabolites, conditiones sine qua non. These proven technologies require experts in ecology, botany, microbiology, genetics, physiology, fermenta- tion technologies, chemistry, etc. to be effective and successful in the search for new drugs from nature. New developments and understandings thus contribute to an improved economy of the natural products deliverable in industrial research, the “magic triangle” of “faster, quicker, cheaper”. Efficient physiological investigations aiming at titer improvement of a microbially or plant-derived natural product or the generation of further derivatives play an essential role in avoiding a shortage in supply, often a motivation to disregard natural products in the lead selection discussions. Without a reliable and efficient supply of sufficient material, the prospects of natural products will be compromised and consequently, they will be uncoupled from the quickly emerging and pursued new directions in the science of drug discovery. We compiled recent developments in the understanding of genetics principles, how nature created the generally accepted broad coverage of chemical space, and in the deciphering of silent gene clusters. Both research directions allow us an in-depth insight into the genetic organization of biosynthetic genes, generating new opportunities in pathway engineering to enlarge chemical diversity
Load more

Recommended publications
  • Alternative Formats If You Require This Document in an Alternative Format, Please Contact: [email protected]
    University of Bath PHD The extraction and chemistry of the metabolites of Mimosa tenuiflora and Papaver somniferum Ninan, Aleyamma Award date: 1990 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 23. Sep. 2021 THE EXTRACTION AND CHEMISTRY OF THE METABOLITES OF MIMOSA TENUIFLORA AND PAP AVER SOMNIFERUM. submitted by ALEYAMMA NINAN for the degree of Doctor of Philosophy of the University of Bath 1990 Attention is drawn to the fact that the copyright of this thesis rests with its author. This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published without prior consent of the author.
    [Show full text]
  • Colchicine Induction of Tetraploid and Octaploid Drosera Strains from D. Rotundifolia and D. Anglica
    © 2021 The Japan Mendel Society Cytologia 86(1): 21–28 Colchicine Induction of Tetraploid and Octaploid Drosera Strains from D. rotundifolia and D. anglica Yoshikazu Hoshi1*, Yuki Homan1 and Takahiro Katogi2 1 Department of Plant Science, School of Agriculture, Tokai University, 9–1–1 Toroku, Higashi-ku, Kumamoto 862–8652, Japan 2 Graduate School of Agriculture, Tokai University, 9–1–1 Toroku, Higashi-ku, Kumamoto 862–8652, Japan Received September 21, 2020; accepted October 15, 2020 Summary Artificial tetraploid and octaploid strains were induced from the wild species of Drosera rotundifolia (2n=2x=20) and D. anglica (2n=4x=40), respectively. The optimal condition of colchicine-treatments for poly- ploid inductions was determined first. A flow cytometry (FCM) analysis showed that the highest mixoploid score of D. rotundifolia was 20% in the treatment of 0.3% for 2 days (d), or 0.5% for 3 d, while the highest mixoploid score of D. anglica was 20% in the treatment of 0.5% for 2 d. Next, to remove chimeric cells, adventitious bud inductions were carried out using the FCM-selected individuals in both species. One strain from a total of 360 colchicine-treated leaf explants in each species had pure chromosome-double numbers of 2n=40 (tetraploid) in D. rotundifolia and 2n=80 (octaploid) in D. anglica. In both species, the guard cell sizes of the chromosome- doubled strains were larger than those of the wild types. The leaves of the chromosome-doubled strains of D. ro- tundifolia were larger than those of the wild diploid D. rotundifolia, while the leaves of the chromosome-doubled strains of D.
    [Show full text]
  • “Biosynthesis of Morphine in Mammals”
    “Biosynthesis of Morphine in Mammals” D i s s e r t a t i o n zur Erlangung des akademischen Grades Doctor rerum naturalium (Dr. rer. nat.) vorgelegt der Naturwissenschaftlichen Fakultät I Biowissenschaften der Martin-Luther-Universität Halle-Wittenberg von Frau Nadja Grobe geb. am 21.08.1981 in Querfurt Gutachter /in 1. 2. 3. Halle (Saale), Table of Contents I INTRODUCTION ........................................................................................................1 II MATERIAL & METHODS ........................................................................................ 10 1 Animal Tissue ....................................................................................................... 10 2 Chemicals and Enzymes ....................................................................................... 10 3 Bacteria and Vectors ............................................................................................ 10 4 Instruments ........................................................................................................... 11 5 Synthesis ................................................................................................................ 12 5.1 Preparation of DOPAL from Epinephrine (according to DUNCAN 1975) ................. 12 5.2 Synthesis of (R)-Norlaudanosoline*HBr ................................................................. 12 5.3 Synthesis of [7D]-Salutaridinol and [7D]-epi-Salutaridinol ..................................... 13 6 Application Experiments .....................................................................................
    [Show full text]
  • Morphine Julie Brousseau a Thesis Submitted
    Synthesis of Carbocycles Using Coinage Metal Catalysis and Formal Synthesis of (±)-Morphine Julie Brousseau A thesis submitted in partial fulfillment of the requirements for the Doctorate in Philosophy degree in Chemistry Department of Chemistry and Biomolecular Sciences Faculty of Science University of Ottawa © Julie Brousseau, Ottawa, Canada, 2020 ABSTRACT Coinage metals such as copper, silver and gold have captivated mankind with their desirable qualities and social value. Recently, these metals have peaked the interests of scientists, where organic chemists have used them extensively in the homogenous catalysis of organic transformations. In our laboratory, we exploited their � -Lewis acidic properties to activate alkyne to induce intramolecular cyclization of nucleophilic enol ethers. We discovered that modulating the steric and electronic profiles of the ancillary ligand on the cationic metal complexes allowed for the regioselective control of such reactions. During the exploration of the substrate dependency of these transformations, we discovered that unsubstituted alkynes undergo a 6-endo-dig/acetalization/Prins reaction cascade in the presence of a silver salt such as [(BrettPhos)Ag(MeCN)]SbF6, resulting in the formation of highly strained polycycles. We have demonstrated that the formation of these products is initiated by a selective 6-endo-dig cyclization. Further mechanistic studies suggested that the reaction may occur through silver dual catalysis using deuterium-labelling experiments, however, single activation of the starting material would lead to the same product and thus both mechanisms were proposed. The further reactivity of these interesting polycyclic products was also explored. ii OTIPS R2 O OTIPS R1 [(BrettPhos)Ag(MeCN)]SbF6 (10 mol%) DCM, 60°C, 36h R1 9 Examples O R2 23-95% Yields Via O H/[Ag] R1 [Ag] O R2 Total synthesis of natural products is often referred to as an art, as it defines the boundaries of organic chemistry.
    [Show full text]
  • Gr up Industrial Microbiology & Biotechnology
    SMGr up Industrial Microbiology & Biotechnology Sandeep Tiwari1, Syed Babar Jamal1, Paulo Vinícius Sanches Daltro de Carvalho1, Syed Shah Hassan1, Artur Silva2 and Vasco Azevedo1 1Universidade Federal de Minas Gerais, UFMG, Brazil 2Universidade Federal do Pará, Belém, PA, Brazil. *Corresponding author: Vasco Azevedo, Universidade Federal de Minas Gerais/Instituto de CiênciasBiológicas, Minas Gerais, Brazil, Email: [email protected] Published Date: February 15, 2015 ABSTRACT Microbes are small living organisms, quite diverse and adapt to various environments. They live on our planet long before that markedly effects the human, animals and plants life. Biotechnologically, molecular genetics of microbes is systematically manipulated, enable them possible through transfer of human insulin gene to a bacterium to treat diabetes, a milestone in for the production of beneficial products. The large-scale production of insulin was made the history of biotechnology. The microbial cultures are managed, monitored and maintained for their genotype/phenotype stability. Bacteria are one of the biotechnologically important microbes for example Escherichia coli, some species of lactic acid bacteria, and some viruses Using such as bacteriophages etc. recognized as anti-cancer oncolytic viruses. Moreover, yeast has also been used with broad-spectrum applications, such as Saccharomyces cerevisiae. biologically active primary and secondary metabolites like ethanol and antibiotics have been diverse genetic technologies, a number of beneficial products like microbial polymers, produced so far and used. Here, it would be injustice not to comment on the importance of vaccines for several infectious diseases through their ability to trigger the host immune system. Furthermore, roles of microorganisms in the production of pharmaceutical proteins A Text Book of Biotechnology | www.smgebooks.com 1 Copyright Azevedo V.
    [Show full text]
  • Improved Taxonomy of the Genus Streptomyces
    UNIVERSITEIT GENT Faculteit Wetenschappen Vakgroep Biochemie, Fysiologie & Microbiologie Laboratorium voor Microbiologie Improved taxonomy of the genus Streptomyces Benjamin LANOOT Scriptie voorgelegd tot het behalen van de graad van Doctor in de Wetenschappen (Biochemie) Promotor: Prof. Dr. ir. J. Swings Co-promotor: Dr. M. Vancanneyt Academiejaar 2004-2005 FACULTY OF SCIENCES ____________________________________________________________ DEPARTMENT OF BIOCHEMISTRY, PHYSIOLOGY AND MICROBIOLOGY UNIVERSITEIT LABORATORY OF MICROBIOLOGY GENT IMPROVED TAXONOMY OF THE GENUS STREPTOMYCES DISSERTATION Submitted in fulfilment of the requirements for the degree of Doctor (Ph D) in Sciences, Biochemistry December 2004 Benjamin LANOOT Promotor: Prof. Dr. ir. J. SWINGS Co-promotor: Dr. M. VANCANNEYT 1: Aerial mycelium of a Streptomyces sp. © Michel Cavatta, Academy de Lyon, France 1 2 2: Streptomyces coelicolor colonies © John Innes Centre 3: Blue haloes surrounding Streptomyces coelicolor colonies are secreted 3 4 actinorhodin (an antibiotic) © John Innes Centre 4: Antibiotic droplet secreted by Streptomyces coelicolor © John Innes Centre PhD thesis, Faculty of Sciences, Ghent University, Ghent, Belgium. Publicly defended in Ghent, December 9th, 2004. Examination Commission PROF. DR. J. VAN BEEUMEN (ACTING CHAIRMAN) Faculty of Sciences, University of Ghent PROF. DR. IR. J. SWINGS (PROMOTOR) Faculty of Sciences, University of Ghent DR. M. VANCANNEYT (CO-PROMOTOR) Faculty of Sciences, University of Ghent PROF. DR. M. GOODFELLOW Department of Agricultural & Environmental Science University of Newcastle, UK PROF. Z. LIU Institute of Microbiology Chinese Academy of Sciences, Beijing, P.R. China DR. D. LABEDA United States Department of Agriculture National Center for Agricultural Utilization Research Peoria, IL, USA PROF. DR. R.M. KROPPENSTEDT Deutsche Sammlung von Mikroorganismen & Zellkulturen (DSMZ) Braunschweig, Germany DR.
    [Show full text]
  • Structural Diversity in Echinocandin Biosynthesis: the Impact of Oxidation Steps and Approaches Toward an Evolutionary Explanation
    Z. Naturforsch. 2017; 72(1-2)c: 1–20 Wolfgang Hüttel* Structural diversity in echinocandin biosynthesis: the impact of oxidation steps and approaches toward an evolutionary explanation DOI 10.1515/znc-2016-0156 can be well applied to parts of the pathway; however, thus Received July 29, 2016; revised July 29, 2016; accepted August 28, far, there is no comprehensive theory that could explain 2016 the entire biosynthesis. Abstract: Echinocandins are an important group of cyclic Keywords: antifungals; gene clusters; metabolic diversity; non-ribosomal peptides with strong antifungal activ- non-ribosomal peptide biosynthesis; secondary meta- ity produced by filamentous fungi from Aspergillaceae bolism; filamentous fungi. and Leotiomycetes. Their structure is characterized by numerous hydroxylated non-proteinogenic amino acids. Biosynthetic clusters discovered in the last years contain up to six oxygenases, all of which are involved in amino 1 Introduction acid modifications. Especially, variations in the oxidation Echinocandins are fungal non-ribosomal cyclic hexapep- pattern induced by these enzymes account for a remark- tides with a fatty acid side chain attached to a dihydroxy- able structural diversity among the echinocandins. This ornithine residue. As they are specific noncompetitive review provides an overview of the current knowledge of inhibitors of the β-1,3-glucan synthase involved in fungal echinocandin biosynthesis with a special focus on diver- cell wall biosynthesis, they have a pronounced antifungal sity-inducing oxidation steps. The emergence of metabolic bioactivity. Although natural echinocandins are not of diversity is further discussed on the basis of a comprehen- clinical use due to their toxicity and low solubility, chemi- sive overview of the structurally characterized echinocan- cal derivatives such as caspofungin, anidulafungin, and dins, their producer strains and biosynthetic clusters.
    [Show full text]
  • Ancestral Class-Promiscuity As a Driver of Functional Diversity in the BAHD
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.18.385815; this version posted November 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Ancestral class-promiscuity as a driver of functional diversity in the 2 BAHD acyltransferase family in plants 3 Lars H. Kruse1, Austin T. Weigle3, Jesús Martínez-Gómez1,2, Jason D. Chobirko1,5, Jason 4 E. Schaffer6, Alexandra A. Bennett1,7, Chelsea D. Specht1,2, Joseph M. Jez6, Diwakar 5 Shukla4, Gaurav D. Moghe1* 6 Footnotes: 7 1 Plant Biology Section, School of Integrative Plant Sciences, Cornell University, Ithaca, 8 NY, 14853, USA 9 2 L.H. Bailey Hortorium, Cornell University, Ithaca, NY, 14853, USA 10 3 Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, 11 USA 12 4 Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana- 13 Champaign, Urbana, IL, 61801, USA 14 5 Present address: Department of Molecular Biology and Genetics, Cornell University, 15 Ithaca, NY, 14853, USA 16 6 Department of Biology, Washington University in St. Louis, St. Louis, MO, 63130, USA 17 7 Present address: Institute of Analytical Chemistry, Universität für Bodenkultur Wien, 18 Vienna, 1190, Austria 19 20 * Corresponding author: [email protected] 21 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.18.385815; this version posted November 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications Yazan H
    University of Arkansas, Fayetteville ScholarWorks@UARK Theses and Dissertations 8-2013 Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications Yazan H. Akkam University of Arkansas, Fayetteville Follow this and additional works at: http://scholarworks.uark.edu/etd Part of the Biochemistry Commons, Medicinal and Pharmaceutical Chemistry Commons, and the Molecular Biology Commons Recommended Citation Akkam, Yazan H., "Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications" (2013). Theses and Dissertations. 908. http://scholarworks.uark.edu/etd/908 This Dissertation is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of ScholarWorks@UARK. For more information, please contact [email protected], [email protected]. Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications Design, Development, and Characterization of Novel Antimicrobial Peptides for Pharmaceutical Applications A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Cell and Molecular Biology by Yazan H. Akkam Jordan University of Science and Technology Bachelor of Science in Pharmacy, 2001 Al-Balqa Applied University Master of Science in Biochemistry and Chemistry of Pharmaceuticals, 2005 August 2013 University of Arkansas This dissertation is approved for recommendation to the Graduate Council. Dr. David S. McNabb Dissertation Director Professor Roger E. Koeppe II Professor Gisela F. Erf Committee Member Committee Member Professor Ralph L. Henry Dr. Suresh K. Thallapuranam Committee Member Committee Member ABSTRACT Candida species are the fourth leading cause of nosocomial infection. The increased incidence of drug-resistant Candida species has emphasized the need for new antifungal drugs.
    [Show full text]
  • Species Accounts
    Species accounts The list of species that follows is a synthesis of all the botanical knowledge currently available on the Nyika Plateau flora. It does not claim to be the final word in taxonomic opinion for every plant group, but will provide a sound basis for future work by botanists, phytogeographers, and reserve managers. It should also serve as a comprehensive plant guide for interested visitors to the two Nyika National Parks. By far the largest body of information was obtained from the following nine publications: • Flora zambesiaca (current ed. G. Pope, 1960 to present) • Flora of Tropical East Africa (current ed. H. Beentje, 1952 to present) • Plants collected by the Vernay Nyasaland Expedition of 1946 (Brenan & collaborators 1953, 1954) • Wye College 1972 Malawi Project Final Report (Brummitt 1973) • Resource inventory and management plan for the Nyika National Park (Mill 1979) • The forest vegetation of the Nyika Plateau: ecological and phenological studies (Dowsett-Lemaire 1985) • Biosearch Nyika Expedition 1997 report (Patel 1999) • Biosearch Nyika Expedition 2001 report (Patel & Overton 2002) • Evergreen forest flora of Malawi (White, Dowsett-Lemaire & Chapman 2001) We also consulted numerous papers dealing with specific families or genera and, finally, included the collections made during the SABONET Nyika Expedition. In addition, botanists from K and PRE provided valuable input in particular plant groups. Much of the descriptive material is taken directly from one or more of the works listed above, including information regarding habitat and distribution. A single illustration accompanies each genus; two illustrations are sometimes included in large genera with a wide morphological variance (for example, Lobelia).
    [Show full text]
  • Feasibility Study on Opium Licensing in Afghanistan
    FEASIBILITY STUDY ON OPIUM LICENSING IN AFGHANISTAN FOR THE PRODUCTION OF MORPHINE AND OTHER ESSENTIAL MEDICINES ﻣﻄﺎﻟﻌﻪ اﻣﮑﺎﻧﺎت در ﻣﻮرد ﺟﻮاز دهﯽ ﺗﺮﻳﺎک در اﻓﻐﺎﻧﺴﺘﺎن ﺑﺮای ﺗﻮﻟﻴﺪ ﻣﻮرﻓﻴﻦ و ادوﻳﻪ ﺟﺎت ﺿﺮوری دﻳﮕﺮ Initial Findings – September 2005 Kabul, Afghanistan The British Institute of International and Comparative Law Hugo Warner • University of Calgary Peter Facchini - Jill Hagel University of Ghent Brice De Ruyver - Laurens van Puyenbroeck University of Kabul Abdul Aziz Ali Ahmad - Osman Babury Cheragh Ali Cheragh - Mohammad Yasin Mohsini University of Lisbon Vitalino Canas - Nuno Aureliano • Shruti Patel • University of Toronto Benedikt Fischer Todd Culbert - Juergen Rehm • Wageningen University Jules Bos - Suzanne Pegge • Ali Wardak • The Senlis Council Gabrielle Archer - Juan Arjona - Luke Bryant Marc Das Gupta - Furkat Elmirzaev - Guillaume Fournier Jane Francis - Thalia Ioannidou - Ernestien Jensema Manna Kamio Badiella - Jorrit Kamminga - Fabrice Pothier Emmanuel Reinert - David Spivack - Daniel Werb FEASIBILITY STUDY ON OPIUM LICENSING IN AFGHANISTAN FOR THE PRODUCTION OF MORPHINE AND OTHER ESSENTIAL MEDICINES Initial Findings – September 2005 Kabul, Afghanistan Study Commissioned by The Senlis Council Study Edited and coordinated by David Spivack Editorial team: Juan Arjona, Jane Francis, Thalia Ioannidou, Ernestien Jensema, Manna Kamio Badiella, Fabrice Pothier. Published 2005 by MF Publishing Ltd 17 Queen Anne’s Gate, London SW1H 9BU, UK ISBN: 0-9550798-2-9 Printed and bound in Afghanistan by Jehoon; Printing Press Other publications
    [Show full text]
  • 102 4. Biosynthesis of Natural Products Derived from Shikimic Acid
    102 4. Biosynthesis of Natural Products Derived from Shikimic Acid 4.1. Phenyl-Propanoid Natural Products (C6-C3) The biosynthesis of the aromatic amino acids occurs through the shikimic acid pathway, which is found in plants and microorganisms (but not in animals). We (humans) require these amino acids in our diet, since we are unable to produce them. For this reason, molecules that can inhibit enzymes on the shikimate pathway are potentially useful as antibiotics or herbicides, since they should not be toxic for humans. COO COO NH R = H Phenylalanine 3 R = OH Tyrosine R NH3 N Tryptophan H The aromatic amino acids also serve as starting materials for the biosynthesis of many interesting natural products. Here we will focus on the so-called phenyl-propanoide (C6-C3) natural products, e.g.: OH OH OH HO O HO OH HO O Chalcone OH O a Flavone OH O OH O a Flavonone OH OH Ar RO O O O HO O O OH O OR OH Anthocyanine OH O a Flavonol Podophyllotoxin MeO OMe OMe OH COOH Cinnamyl alcohol HO O O Cinnamic acid OH (Zimtsäure) Umbellierfone OH a Coumarin) MeO OH O COOH HO Polymerization OH Wood OH HO OH O OH MeO OMe Shikimic acid O HO 4.2. Shikimic acid biosynthesis The shikimic acid pathway starts in carbohydrate metabolism. Given the great social and industrial significance of this pathway, the enzymes have been intensively investigated. Here we will focus on the mechanisms of action of several key enzymes in the pathway. The following Scheme shows the pathway to shikimic acid: 103 COO- COO- Phosphoenolpyruvate HO COO- 2- O O3P-O 2- O3P-O DHQ-Synthase
    [Show full text]